Clinical trial
Assessing Immunogenicity of Measles-Rubella Vaccine at 6 and 9 Months of Age
NCT03071575 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing Immunogenicity of Measles-Rubella Vaccine at 6 and 9 Months of Age
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 9, 2017
- Completion date
- March 18, 2018
- Enrollment
- 637 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.